Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer
about
Development of Photoonycholysis with Vandetanib Therapy.Selective use of vandetanib in the treatment of thyroid cancer.Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer.BRAF mutation in papillary thyroid carcinoma (PTC) and its association with clinicopathological features and systemic inflammation response index (SIRI)
P2860
Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Overview and management of der ...... s for medullary thyroid cancer
@ast
Overview and management of der ...... s for medullary thyroid cancer
@en
Overview and management of der ...... s for medullary thyroid cancer
@nl
type
label
Overview and management of der ...... s for medullary thyroid cancer
@ast
Overview and management of der ...... s for medullary thyroid cancer
@en
Overview and management of der ...... s for medullary thyroid cancer
@nl
prefLabel
Overview and management of der ...... s for medullary thyroid cancer
@ast
Overview and management of der ...... s for medullary thyroid cancer
@en
Overview and management of der ...... s for medullary thyroid cancer
@nl
P2860
P356
P1433
P1476
Overview and management of der ...... s for medullary thyroid cancer
@en
P2093
Mark Agulnik
Richard T Kloos
P2860
P304
P356
10.1089/THY.2013.0700
P407
P577
2014-07-15T00:00:00Z